Search all news & insights
Latest news
Show
news from
- all companies
- Syncona
- all Late-stage clinical companies companies
- Autolus Therapeutics
- Beacon Therapeutics
- all Clinical companies companies
- Achilles Therapeutics
- SwanBio Therapeutics
- Freeline Therapeutics
- Quell Therapeutics
- all Pre-clinical companies companies
- Resolution Therapeutics
- Anaveon
- Purespring Therapeutics
- Clade Therapeutics
- OMass Therapeutics
- Kesmalea Therapeutics
- Mosaic Therapeutics
- all Syncona investments companies
- Forcefield Therapeutics
Latest insights & articles
Show
insights & articles from
- all companies
- Syncona
- all Late-stage clinical companies companies
- Autolus Therapeutics
- Beacon Therapeutics
- all Clinical companies companies
- Achilles Therapeutics
- SwanBio Therapeutics
- Freeline Therapeutics
- Quell Therapeutics
- all Pre-clinical companies companies
- Resolution Therapeutics
- Anaveon
- Purespring Therapeutics
- Clade Therapeutics
- OMass Therapeutics
- Kesmalea Therapeutics
- Mosaic Therapeutics
- all Syncona investments companies
- Forcefield Therapeutics
Latest publications & presentations
Show presentations from
- all companies
- Syncona
- all Late-stage clinical companies companies
- Autolus Therapeutics
- Beacon Therapeutics
- all Clinical companies companies
- Achilles Therapeutics
- SwanBio Therapeutics
- Freeline Therapeutics
- Quell Therapeutics
- all Pre-clinical companies companies
- Resolution Therapeutics
- Anaveon
- Purespring Therapeutics
- Clade Therapeutics
- OMass Therapeutics
- Kesmalea Therapeutics
- Mosaic Therapeutics
- all Syncona investments companies
- Forcefield Therapeutics